Department of Internal Medicine, Infectious Diseases, Rheumatology and Endocrinology, Angoulême Hospital, 16959, Angoulême, France.
Department of Infectious Diseases and Internal Medicine, Le Havre Hospital, 76083, Le Havre, France.
J Autoimmun. 2021 Jan;116:102541. doi: 10.1016/j.jaut.2020.102541. Epub 2020 Sep 15.
Adult-onset Still's disease (AOSD) is a rare inflammatory disease that may be life-threatening if complicated by cardiac problems. We performed a retrospective multicenter study to describe the manifestations, treatments and outcomes of cardiac involvement in AOSD.
We reviewed the medical databases of eight centers. All AOSD patients identified as fulfilling Yamagushi's or Fautrel's criteria were included in the study. Cardiac involvement, clinical manifestations, laboratory features, the course of the disease and treatments were evaluated.
We included 96 AOSD patients in this study: 28 (29%) had documented cardiac involvement (AOSD + C group) and 68 (71%) had no cardiac involvement (control group). Cardiac complications were observed at diagnosis in 89% of cases. It were pericarditis (n = 17), tamponade (n = 5), myocarditis (n = 5) and non-infectious endocarditis (n = 1). Levels of leukocytes, neutrophils and C-reactive protein were significantly higher (p = 0.02, p = 0.02 and p = 0.002, respectively in the AOSD + C group than in the control group. Admission to intensive care, and the use of biotherapy were more frequent during follow-up in the AOSD + C group than the control group (p = 0.0001 and p = 0.03 respectively). Cardiac involvement was associated with refractory form in multivariate analyzed (p = 0.01). Corticosteroids were effective with or without methotrexate in 71% of patients but not in severe involvement as myocarditis or tamponade.
Cardiac complications are frequent, inaugural, can be life-threatening and predictive of a refractory course in patients with AOSD. Systematic cardiac screening should be proposed at diagnosis and biotherapy early use should be considered especially in myocarditis.
成人Still 病(AOSD)是一种罕见的炎症性疾病,如果合并心脏问题,可能会危及生命。我们进行了一项回顾性多中心研究,以描述 AOSD 中心脏受累的表现、治疗和结局。
我们回顾了八个中心的医学数据库。所有符合 Yamagushi 或 Fautrel 标准的 AOSD 患者均纳入本研究。评估了心脏受累、临床表现、实验室特征、疾病过程和治疗。
本研究纳入了 96 例 AOSD 患者:28 例(29%)有明确的心脏受累(AOSD+C 组),68 例(71%)无心脏受累(对照组)。心脏并发症在 89%的病例中在诊断时就已经存在。这些并发症包括心包炎(n=17)、心包填塞(n=5)、心肌炎(n=5)和非感染性心内膜炎(n=1)。白细胞、中性粒细胞和 C 反应蛋白水平在 AOSD+C 组明显高于对照组(p=0.02、p=0.02 和 p=0.002)。在随访期间,AOSD+C 组患者更频繁地入住重症监护病房,使用生物治疗(p=0.0001 和 p=0.03)。在多变量分析中,心脏受累与难治性表现相关(p=0.01)。皮质类固醇联合或不联合甲氨蝶呤在 71%的患者中有效,但在心肌炎或心包填塞等严重受累时无效。
心脏并发症在 AOSD 患者中常见,首发,可能危及生命,并预示疾病呈难治性过程。应在诊断时进行系统的心脏筛查,并考虑早期使用生物治疗,尤其是在心肌炎的情况下。